Tirth Plastic Ltd approves preferential issue of up to 45 lakh equity shares

What Tirth Plastic Ltd announced

On 4 July 2026, Tirth Plastic Ltd held a board meeting at its registered office. The board resolved to approve a preferential issue of equity shares of up to 45,00,000 shares (forty‑five lakh) having a face value of Rs 10 per share. The shares are to be offered to persons belonging to the non‑promoter category, subject to the receipt of all required approvals.

Details of the preferential issue

The filing does not specify the issue price, subscription period, or the exact use of proceeds. It merely states that the issue will be carried out in accordance with the Companies Act, 2013 and the SEBI (Issue of Capital and Disclosure) Regulations, 2006. The resolution also notes that the issue will be undertaken only after obtaining the necessary approvals from the stock exchanges, the Securities and Exchange Board of India (SEBI), and any other statutory authorities.

Key points extracted from the board resolution:

• Number of shares: 45,00,000
• Face value: Rs 10 per share
• Target investors: Non‑promoter category
• Approvals required: Stock exchange, SEBI, and other statutory bodies
• Board meeting date: 4 July 2026

Key facts at a glance

Why this matters for investors

A preferential issue allows a company to raise fresh capital by offering shares to a select group of investors, often at a price determined through negotiation rather than a public offer. For existing shareholders, the primary considerations are potential dilution of their holdings and the purpose of the raised funds. Since the filing does not disclose the issue price or the intended use of proceeds, investors cannot yet assess the financial impact. However, the requirement of regulatory clearances means the transaction will only proceed after satisfying compliance checks, which adds a layer of procedural certainty.

Conclusion

Tirth Plastic Ltd’s board has cleared a preferential issue of up to 45 lakh equity shares to non‑promoter investors, subject to statutory approvals. The filing does not reveal the issue price, subscription timeline, or the specific allocation of the capital to be raised. Investors should monitor subsequent disclosures for details on pricing, approvals, and the final terms of the issue.